September 07, 2021
Article
As with previous studies, the investigators found that the biologic aided in reducing severe exacerbations and improving lung function in patients with evidence type 2 inflammation.
Investigators believe the current climate crisis can lead to an increased risk of COPD exacerbations and mortality rates, both of which have been noted in prior research.
September 11, 2020
HRV-induced cytokine responses were reduced in patients with severe asthma.
Pulmonary conditions like asthma could often lead to the development of chronic cough.
Despite not being able to attend conferences live, there are some advantages to a virtual conference.
The molecular mechanisms of steroid resistance suggest the P13K/Akt signaling pathway and the MAPK signaling pathway are involved.
New cohort analysis shows an over-reliance on therapy designed as an add-on for asthma control.
September 10, 2020
Asthma patients have not had higher rates of negative outcomes from COVID-19 than other individuals.
The biologic drug is set to be used as a combination therapy for asthma.
In a study presented at ERS, researchers IOS could be used for assessment level of asthma control in both adult and pediatric patients.
Real-World Study Shows RBX2660 Improves Recurrent C Difficile Infection
Sleep Pharmacotherapy, Melatonin, and the Link to Substance Use Disorders
Mental Health Disparities Among the Hispanic Population
